Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 shot. The missed deadline comes shortly after the departure of the FDA’s chief vaccine official Peter Marks, M.D.,
read more
Approval extends ustekinumab’s use to younger patients More: European Commission approves ustekinumab for paediatric Crohn’s disease Source: News
read more
Collaboration introduces automation to enhance efficiency More: Elekta and Azra AI partner to advance cancer registry operations with AI Source: News
read moreIn response to a request from the European Medicines Agency following the death of a 16-year-old patient in the U.S., Sarepta and Roche have temporarily halted three clinical trials in Europe of their Duchenne muscular dystrophy gene therapy Elevidys. More:
read moreCamilla Sylvest is stepping down from her role as executive vice president, commercial strategy and corporate affairs after nearly three decades of service to the Danish drugmaker. More: Novo's commercial strategy head hits the exit, prompting a slew of executive
read moreAs Nxera Pharma proceeds into the “next era” implied by its name—following a rebrand from Sosei Group last year—the Japanese drugmaker is adding a new executive to help guide its growth plans. More: Nxera Pharma appoints AstraZeneca alum as inaugural
read more© 1994 - 2025 B.M. Pharmaceuticals